Live Breaking News & Updates on Intravenous Drip Infusion

Stay updated with breaking news from Intravenous drip infusion. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Anticancer Agent Remitoro Intravenous Drip Infusion 300 microgram (Denileukin Diftitox (Genetical Recombination)) Launched in Japan

For Peripheral T-Cell Lymphoma and Cutaneous T-Cell Lymphoma
Tokyo, May 19, 2021 - (JCN Newswire) - Eisai Co., Ltd. announced today that it has launched the anticancer agent Remitoro® for Intravenous Drip Infusion 300µg (Denileukin Diftitox (Genetical Recombination)) with the indications of relapsed or refractory Peripheral T-cell Lymphoma (PTCL) and relapsed or refractory Cutaneous T-cell Lymphoma (CTCL), in Japan. Eisai obtained the manufacturing and marketing approval of Remitoro on March 23, 2021. Remitoro was included to Japan s National Health Insurance Drug Price List on May 19, 2021.
The agent is a fusion protein consisting of interleukin-2 (IL-2) and partial sequence of diphtheria toxin, and specifically binds to the IL-2 receptor on the surface of tumoral lymphocytes. The antitumor efficacy of denileukin diftitox is believed to depend on the intracellular delivery of diphtheria toxin fragment which inhibits protein synthesis and induce cell death. ....

Kostenloser Wertpapierhandel , Eisai Co Ltd , Ministry Of Health , Study Group For Unapproved Drugs Off , Peripheralt Cell Lymphoma , Cutaneoust Cell , Intravenous Drip Infusion , Denileukin Diftitox , Genetical Recombination , Cutaneoust Cell Lymphoma , National Health Insurance Drug Price List , Off Label Drugs , High Medical , Anti Cancer , ேசை இணை லிமிடெட் , அமைச்சகம் ஆஃப் ஆரோக்கியம் , தேசிய ஆரோக்கியம் காப்பீடு மருந்து ப்ரைஸ் பட்டியல் , ஆஃப் லேபிள் மருந்துகள் , உயர் மருத்துவ , எதிர்ப்பு புற்றுநோய் ,

acnnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from acnnewswire.com Daily Mail and Mail on Sunday newspapers.

Eisai Co Ltd , Ministry Of Health , Study Group For Unapproved Drugs Off , Intravenous Drip Infusion , Denileukin Diftitox , Genetical Recombination , Peripheralt Cell Lymphoma , Cutaneoust Cell , Cutaneoust Cell Lymphoma , National Health Insurance Drug Price List , Off Label Drugs , High Medical , ேசை இணை லிமிடெட் , அமைச்சகம் ஆஃப் ஆரோக்கியம் , தேசிய ஆரோக்கியம் காப்பீடு மருந்து ப்ரைஸ் பட்டியல் , ஆஃப் லேபிள் மருந்துகள் , உயர் மருத்துவ ,